Grant name: Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
Funding organization: National Institutes of Health (NIH)
Total funding amount: Approximately $2 million for fiscal year 2024
Duration: Up to four years
Primary objective: Support high-risk, high-impact research on vaccine approaches to prevent HIV acquisition or ongoing infection
Key stakeholders: Principal investigators, research institutions, and the broader scientific community
Funding source: NIH
Funding type: Grant
Significance: Addresses a major public health priority in HIV prevention
Grant frequency: One-time funding opportunity
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Small Businesses
Local Governments
State Governments
County Governments
City or Township Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)
Federal Government Agencies
U.S. Territory or Possession
Other: Independent School Districts, Public Housing Authorities, Faith-based Organizations, Regional Organizations, Foreign Institutions
No specific qualifications or certifications mentioned
Principal Investigators must have the skills and resources necessary to carry out the proposed research
Eligible organizations can be based in the U.S. or foreign institutions
High-risk, high-impact early discovery research on HIV vaccine approaches
Encouragement of novel exploratory research strategies
Individuals living with HIV
Scientific community engaged in HIV research
Innovative vaccine strategies that can significantly impact HIV prevention
Interdisciplinary approaches among virologists, immunologists, and other specialists are encouraged
Projects must include measurable Go/No-Go criteria
Application budgets limited to $350,000 per year in direct costs
Additional $150,000 per year allowed for research involving nonhuman primates or humanized mice
Open Date: July 02, 2023
Application Due Dates: August 02, 2023; August 02, 2024; August 01, 2025
Must comply with NIH Grants Policy Statement
No clinical trials allowed
Follow instructions in the SF424 (R&R) Application Guide
Include Go/No-Go decision criteria in the application